Differential diagnoses: How to determine cause of visual field loss

Article

Management decisions for a patient who presents with a visual field defect should never be made before considering a host of other etiologies that can masquerade as glaucoma by the type of visual field loss.

New York-Management decisions for a patient who presents with a visual field defect (VFD) should never be made before considering a host of other etiologies that can masquerade as glaucoma by the type of visual field loss (VFL), said Sherry J. Bass, OD, FAAO, at International Vision Expo East.

Consider big picture

VFL associated with glaucoma presents initially as paracentral defects with progression to nasal step defects, arcuate and Bjerrum defects, altitudinal defects, and ultimately, if the disease is not controlled, peripheral field constriction. For each of these types of defects, there are different etiologies to consider as an alternative diagnosis.

Non-glaucomatous etiologies of paracentral field loss include hereditary macular disease, such as Stargardt macular degeneration and cone dystrophy, and optic pits. Superior paracentral VFLs can be found in patients with a hereditary macular disease as a result of their typical use of superior eccentric fixation to achieve better vision.

In patients with an optic pit, usually located at the inferior temporal border of the optic nerve head, paracentral field loss is secondary to loss of the retinal nerve fiber layer between the macula and optic nerve that can exist in this condition, Dr. Bass explained.

Nasal field defects are also a sign of early glaucoma but can alternatively be caused by optic disc drusen. Diagnosis of optic disc drusen may be challenged by the fact that the lesions may be buried in younger patients.

"The finding of an optic nerve head with blurry disc borders and no cupping in a patient with a nasal field defect should suggest the diagnosis of optic nerve drusen," Dr. Bass said.

"Further evaluation should include B-scan ultrasonography," she continued. "However, this imaging is only effective for identifying drusen that are calcified, which includes about 50% of disc drusen."

Recent Videos
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
© 2024 MJH Life Sciences

All rights reserved.